DNA X Inc.
SONM | NASDAQ
$4
-$0.05 (-1.23%)
Sep 22, 2026, 12:40 PM ET · Market open
-1.23%
(1D)Rating
Updated: Aug 17, 2026Key Statistics
Market Data
Market Cap $5.95M
1D Range
3.91 4.47
52W Range
2.52 16.97
Valuation (TTM)
PE -0.30
PB -5.00
EV/EBITDA -2.89
Valuation (NTM)
Forward PE 0.14
Forward PEG -0.10
Price Target N/A
Cash Flow
FCF Yield -236.9%
SBC Adj. FCF Yield -223.7%
SBC Impact -5.6%
Margins
Gross Margin 48.4%
Operating Margin 15.1%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -146.8% |
-40.9%
Dil EPS 3Y | 5Y -79.6% |
29.3%
FCF 3Y | 5Y -40.2% |
8.7%
Returns
ROA -189.2%
ROE 391.0%
ROIC -228.3%
Financial Health
Net Debt
$1.5M
Current Ratio 0.57
Interest Coverage -3.30
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in deliv...
Sector Technology
Industry Communication Equipment
Employees 4
IPO Date May 9, 2019
Website ir.dna-x.global
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SONM